Procter & Gamble offers $4B in senior notes
Interest payments begin April 30, 2027, and P&G may redeem any series before maturity using a Treasury-based pricing formula.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
The Procter & Gamble Company is offering $4,000,000,000 aggregate principal amount of senior notes in four series: $750,000,000 at 5.125% due October 30, 2031; $750,000,000 at 5.300% due October 30, 2033; $1,250,000,000 at 5.450% due October 30, 2036; and $1,250,000,000 at 5.900% due October 30, 2056. Interest accrues from October 30, 2026, and is payable semiannually beginning April 30, 2027. The table lists $3,970,980,000 in proceeds to the company before expenses and a $22,187,500 underwriting discount.
For the three months ended September 30, 2026, net sales were $23.276 billion, compared with $22.386 billion for the three months ended September 30, 2025; net earnings attributable to P&G were $4.731 billion and $4.750 billion, respectively. Total debt was $38.925 billion as of September 30, 2026, excluding the $4,000,000,000 of notes offered.
Filing Explained
The notes are senior unsecured debt ranking equally with P&G’s other unsecured, unsubordinated debt; the indenture sets no limit on additional borrowing or securities issuance by P&G or its subsidiaries, so this financing adds no stated debt ceiling.
Key Figures
Key Terms
senior debt financial
Treasury Rate financial
defeasance financial
book-entry form technical
indenture financial
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much is PG's notes offering?
What are the rates and maturities of PG's notes?
When does PG pay interest on the notes?
Can PG redeem the notes before maturity?
AI-generated analysis. How Rhea-AI works. Not financial advice.

Initial Offering Price | Underwriting Discount | Proceeds, Before Expenses, to us | ||||||||||
Per Note | Total | Per Note | Total | Per Note | Total | |||||||
5.125% Notes .......... | 99.965% | $749,737,500 | 0.350% | $2,625,000 | 99.615% | $747,112,500 | ||||||
5.300% Notes .......... | 99.954% | $749,655,000 | 0.400% | $3,000,000 | 99.554% | $746,655,000 | ||||||
5.450% Notes .......... | 99.642% | $1,245,525,000 | 0.450% | $5,625,000 | 99.192% | $1,239,900,000 | ||||||
5.900% Notes .......... | 99.860% | $1,248,250,000 | 0.875% | $10,937,500 | 98.985% | $1,237,312,500 | ||||||
Total ....................... | $3,993,167,500 | $22,187,500 | $3,970,980,000 | |||||||||
Citigroup | Deutsche Bank Securities | Goldman Sachs & Co. LLC | HSBC | Morgan Stanley |
BofA Securities | Barclays | BBVA | BNP PARIBAS | RBC Capital Markets |
Bank of China | PNC Capital Markets LLC | Siebert Williams Shank | Standard Chartered Bank | |
Page | |
About This Prospectus Supplement ............................................................................................................ | S-1 |
The Company ................................................................................................................................................. | S-2 |
Risk Factors .................................................................................................................................................... | S-3 |
Summary Consolidated Financial Information ........................................................................................... | S-12 |
Capitalization .................................................................................................................................................. | S-13 |
Description of the Notes ................................................................................................................................ | S-14 |
Certain U.S. Federal Tax Considerations ................................................................................................... | S-25 |
Underwriting .................................................................................................................................................... | S-31 |
Validity of the Notes ....................................................................................................................................... | S-36 |
Incorporation of Certain Information by Reference ................................................................................... | S-36 |
Where You Can Find More Information ...................................................................................................... | S-36 |
Page | |
About This Prospectus .................................................................................................................................. | 1 |
The Company ................................................................................................................................................. | 2 |
Cautionary Note Regarding Forward-Looking Statements ...................................................................... | 3 |
Risk Factors .................................................................................................................................................... | 5 |
Use of Proceeds ............................................................................................................................................. | 6 |
Description of Debt Securities ...................................................................................................................... | 7 |
Plan of Distribution ......................................................................................................................................... | 15 |
Legal Opinions ................................................................................................................................................ | 17 |
Experts ............................................................................................................................................................. | 17 |
Incorporation of Certain Information by Reference ................................................................................... | 17 |
Where You Can Find More Information ...................................................................................................... | 18 |
Three Months Ended September 30, | ||||
2026 | 2025 | |||
(Amounts in Millions Except Per Share Amounts) | ||||
NET SALES ........................................................................................................ | $23,276 | $22,386 | ||
Cost of products sold ................................................................................... | 11,678 | 10,887 | ||
Selling, general and administrative expense ............................................ | 5,661 | 5,643 | ||
OPERATING INCOME ..................................................................................... | 5,937 | 5,856 | ||
Interest expense ........................................................................................... | (223) | (197) | ||
Interest income .............................................................................................. | 102 | 108 | ||
Other non-operating income, net ............................................................... | 207 | 268 | ||
EARNINGS BEFORE INCOME TAXES ........................................................ | 6,023 | 6,034 | ||
Income taxes ................................................................................................. | 1,267 | 1,253 | ||
NET EARNINGS ................................................................................................ | 4,757 | 4,781 | ||
Less: Net earnings attributable to noncontrolling interests .................... | 26 | 31 | ||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE ................. | $4,731 | $4,750 | ||
NET EARNINGS PER COMMON SHARE(1) | ||||
Basic ............................................................................................................... | $2.00 | $2.00 | ||
Diluted ............................................................................................................. | $1.97 | $1.95 | ||
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ............................................................................................. | 2,407.2 | 2,436.8 | ||
As of September 30, 2026 | As of June 30, 2026 | |||
(Amounts in Millions) | ||||
WORKING CAPITAL ....................................................................................... | $(12,488) | $(12,486) | ||
TOTAL ASSETS ............................................................................................... | $133,132 | $126,521 | ||
LONG-TERM DEBT ........................................................................................ | $21,897 | $22,842 | ||
TOTAL SHAREHOLDERS’ EQUITY ............................................................ | $55,337 | $54,311 | ||
September 30, 2026 | ||
(In Millions of Dollars Except Per Share Amounts) | ||
Debt: | ||
Debt due within one year (1) ......................................................................................... | $17,028 | |
Long-term debt ................................................................................................................ | 21,897 | |
Total Debt (2) ................................................................................................................... | 38,925 | |
Shareholders’ Equity: | ||
Preferred stock ................................................................................................................ | 747 | |
Common stock, stated value $1 per share; 10,000,000,000 shares authorized, 2,317,783,143 outstanding ................................................................. | 4,009 | |
Additional paid-in capital ............................................................................................... | 69,700 | |
Reserve for Employee Stock Ownership Plan debt retirement ............................... | (555) | |
Accumulated other comprehensive loss ..................................................................... | (12,652) | |
Treasury stock ................................................................................................................. | (144,173) | |
Retained earnings .......................................................................................................... | 138,021 | |
Noncontrolling interest ................................................................................................... | 239 | |
Total Shareholders’ Equity ........................................................................................ | 55,337 | |
Total Capitalization ......................................................................................................... | $94,262 |
Underwriters | Principal Amount of 5.125% Notes | Principal Amount of 5.300% Notes | Principal Amount of 5.450% Notes | Principal Amount of 5.900% Notes | ||||
Citigroup Global Markets Inc. ........................ | $121,875,000 | $121,875,000 | $203,125,000 | $203,125,000 | ||||
Deutsche Bank Securities Inc. ....................... | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
Goldman Sachs & Co. LLC ............................ | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
HSBC Securities (USA) Inc. ........................... | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
Morgan Stanley & Co. LLC ............................ | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
BofA Securities, Inc. ........................................ | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
Barclays Capital Inc. ....................................... | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
BBVA Securities Inc. ....................................... | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
BNP Paribas Securities Corp. ....................... | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
RBC Capital Markets, LLC ............................. | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
Bank of China (Europe) S.A. ......................... | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
PNC Capital Markets LLC .............................. | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
Siebert Williams Shank & Co., LLC .............. | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
Standard Chartered Bank ............................... | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
Total .............................................................. | $750,000,000 | $750,000,000 | $1,250,000,000 | $1,250,000,000 |
The Procter & Gamble Company | |
Attn: Investor Relations | |
One Procter & Gamble Plaza | |
Cincinnati, Ohio 45202 | |
Telephone: (513) 983-2414 |
Page | |
About This Prospectus .................................................................................................................................. | 1 |
The Company ................................................................................................................................................. | 2 |
Cautionary Note Regarding Forward-Looking Statements ...................................................................... | 3 |
Risk Factors .................................................................................................................................................... | 5 |
Use of Proceeds ............................................................................................................................................. | 6 |
Description of Debt Securities ...................................................................................................................... | 7 |
Plan of Distribution ......................................................................................................................................... | 15 |
Legal Opinions ................................................................................................................................................ | 17 |
Experts ............................................................................................................................................................. | 17 |
Incorporation of Certain Information by Reference ................................................................................... | 17 |
Where You Can Find More Information ...................................................................................................... | 18 |
The Procter & Gamble Company | |
Attn: Investor Relations | |
One Procter & Gamble Plaza | |
Cincinnati, Ohio 45202 | |
Telephone: (513) 983-2414 |
